Adicet Bio, Inc.
ACET- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001720580
No open-market purchases or sales by Adicet Bio, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $52.8M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Adicet Bio, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 58 | 81 | +23 |
| Shares | 19.9M | 30.4M | +10.5M (+52.5%) |
| Value | $156.1M | $531.2M | +$375.0M (+240.2%) |
New holders (31)
Institutions that held Adicet Bio, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (8)
Institutions that held Adicet Bio, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Ally Bridge Group (NY) LLC | 425,000 | $3.33M |
| Nantahala Capital Management, LLC | 310,540 | $2.44M |
| 683 Capital Management, LLC | 265,000 | $2.08M |
| Renaissance Technologies LLC | 42,217 | $331.0K |
| Millennium Management LLC | 22,747 | $178.0K |
| SG Americas Securities, LLC | 14,655 | $115.0K |
| Penserra Capital Management LLC | 730 | $5.00K |
| O'Shaughnessy Asset Management, LLC | 50 | $0 |